The functional affinity of IgM rheumatoid factor is related to the disease duration in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 56, Issue 2, 1997, Pages 126-129

  Saraux, A ^a   Bendaoud, B ^a   Dueymes, M ^a   Le Goff, P ^a   Youinou, P ^a  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RHEUMATOID FACTOR;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0030983689     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.2.126     Document Type: Article

References (15)

1. Burastero SE, Casali P, Wilder RL, Notkins AL. Monoreactive high affinity and polyreactive low affinity rheumatoid factor are produced by CD5+Bcells from patients with rheumatoid arthritis. J Exp Med 1988;168:1979-92.
2. Randen I, Brown D, Thompson KM, Hughes-Jones N, Pascual V, Victor K, et al. Clonally related IgM rheumatoid factors undergo affinity maturation in the rheumatoid synovial tissue. J Immunol 1992;148:3296-301.
3. Borretzen M, Randen I, Zdarsky E, Forre O, Natvig JB, Thompson KM. Control of autoantibody affinity by selection against aminoacid replacements in the complementarity-determining regions. Proc Natl Acad Sci USA 1994;91:12917-21.
4. Dalal N, Roman S, Levinson AI. In vitro secretion of IgM rheumatoid factor. Arthritis Rheum 1990;33:1340-6.
5. Kemp M, Husby S, Jensenius JC, Rasmussen GG, Svehag SE. Analysis of rheumatoid factors by a biotin avidin based isotype-spccific ELISA. Acta Pathol Microbiol Immunol Scand C 1985;93:217-23.
6. Chia D, Nasu H, Yamagata J, Harriett EV. Avidity indices of anti IgG antibodies in diseases. Arthritis Rheum 1981; 24:803-8.
7. Rath S, Hogben DN, Devey ME. Functional affinity of IgM rheumatoid factor in patients with rheumatoid arthritis and other autoimmune diseases. Ann Rheum Dis 1988; 47:291-4.
8. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
9. Ritchie DM, Boyle JA, Mclnnes JM, Jasani MK, Dalakos TG, Grietverson P, et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;37:396-406.
10. Lee P, Mukundray JK, Carson-Dick W, Watson-Buchanan W. Evaluation of a functional index in rheumatoid arthritis. Scand J Rheumatol 1973;2:71-3.
11. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
12. Merville P, Dechanet J, Desmouliere A, Durand I, De Bouteiller O, Garrone P, et al. Bel 2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J Exp Med 1996;183:227-36.
13. Youinou P, Keusch J, Casburn-Budd R, Paolozzi L, Lamour A, Le Goff P, et al. Tiopronine-induced reduction of rheumatoid factor functional affinity and asialylated IgG in patients with rheumatoid arthritis. Clin Exp Rheumatol 1992;10:333-8.
14. Youinou P, Monow WJW, Lettin AWF, Lydiard PM, Roitt IW. Specificity of plasma cells in the rheumatoid synovium. I. Immunoglobulin class of antiglobulin-producing cells. Scand J Immunol 1984;20:307-15.
15. Newkirk MM, Fournier MJ, Shiroky J. Rheumatoid factor avidity in patients with rheumatoid arthritis: identification of pathogenic Rfs wich correlate with disease parameters and with the Gal (0) glycoform of IgG. J Clin Immunol 1995;15:250-7.